Profiel
Dorothee Holm-von Laer is associated with ViraTherapeutics GmbH as the founder.
She held the position of Chief Executive & Scientific Officer from 2013 to 2017.
ViraTherapeutics GmbH was founded in 2013.
Eerdere bekende functies van Dorothee Holm-von Laer
Bedrijven | Functie | Einde |
---|---|---|
ViraTherapeutics GmbH
ViraTherapeutics GmbH BiotechnologyHealth Technology ViraTherapeutics GmbH is a biopharmaceutical company that develops virus-based immunotherapeutics for cancer treatment. It specializes in the development of oncolytic cancer vaccines based on Vesicular Stomatitis Virus Glycoprotein G (VSV-GP). The company was founded by Dorothee Holm-von Laer in 2013 and is headquartered in Innsbruck, Austria. | Algemeen Directeur | 30-05-2017 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
ViraTherapeutics GmbH
ViraTherapeutics GmbH BiotechnologyHealth Technology ViraTherapeutics GmbH is a biopharmaceutical company that develops virus-based immunotherapeutics for cancer treatment. It specializes in the development of oncolytic cancer vaccines based on Vesicular Stomatitis Virus Glycoprotein G (VSV-GP). The company was founded by Dorothee Holm-von Laer in 2013 and is headquartered in Innsbruck, Austria. | Health Technology |